Advertisement

Topics

Human medicines European public assessment report (EPAR): Incresync, alogliptin / pioglitazone, Revision: 5, Authorised

09:30 EST 24 Feb 2017 | European Medicines Agency

This article has expired, however you can still download the PDF.
Preview:
...

Other Sources for this Article

Original Article: Human medicines European public assessment report (EPAR): Incresync, alogliptin / pioglitazone, Revision: 5, Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Incresync, alogliptin / pioglitazone, Revision: 5, Authorised"

Advertisement
Quick Search
Advertisement
Advertisement